Morgan Stanley
TRIB

Morgan Stanley’s Trinity Biotech TRIB Stock Holding History

Morgan Stanley’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218 Sell
402
-178
-31% -$131 ﹤0.01% 7692
2025
Q4 		$459 Buy
580
+100
+21% +$98 ﹤0.01% 7517
2025
Q3 		$499 Buy
+480
New +$504 ﹤0.01% 7495
2025
Q2 		– Sell
-2,160
Closed -$1.23K – 8275
2025
Q1 		$1.23K Hold
2,160
– – ﹤0.01% 7256
2024
Q4 		$1.9K Sell
2,160
-500
-19% -$668 ﹤0.01% 7205
2024
Q3 		$2.93K Hold
2,660
– – ﹤0.01% 7050
2024
Q2 		$5.67K Sell
2,660
-250
-9% -$485 ﹤0.01% 6820
2024
Q1 		$5.94K Sell
2,910
-2,911
-50% -$6.82K ﹤0.01% 6848
2023
Q4 		$12.5K Buy
5,821
+2,911
+100% +$6.95K ﹤0.01% 6785
2023
Q3 		$10.7K Sell
2,910
-4,737
-62% -$19.4K ﹤0.01% 6711
2023
Q2 		$36.4K Hold
7,647
– – ﹤0.01% 6340
2023
Q1 		$35.9K Sell
7,647
-120
-2% -$618 ﹤0.01% 6402
2022
Q4 		$38.4K Sell
7,767
-1,190
-13% -$7.21K ﹤0.01% 6404
2022
Q3 		$48K Sell
8,957
-440
-5% -$2.84K ﹤0.01% 6429
2022
Q2 		$57K Sell
9,397
-12,174
-56% -$74.3K ﹤0.01% 6551
2022
Q1 		$115K Buy
21,571
+9,449
+78% +$54.4K ﹤0.01% 6233
2021
Q4 		$87K Buy
12,122
+7,969
+192% +$75.3K ﹤0.01% 6521
2021
Q3 		$45K Buy
4,153
+1,186
+40% +$13.9K ﹤0.01% 6771
2021
Q2 		$43K Sell
2,967
-19,331
-87% -$322K ﹤0.01% 6733
2021
Q1 		$419K Sell
22,298
-21,440
-49% -$516K ﹤0.01% 5248
2020
Q4 		$833K Sell
43,738
-6,525
-13% -$108K ﹤0.01% 4768
2020
Q3 		$508K Buy
50,263
+11,963
+31% +$138K ﹤0.01% 4633
2020
Q2 		$417K Buy
38,300
+26,768
+232% +$204K ﹤0.01% 4695
2020
Q1 		$63K Sell
11,532
-80,373
-87% -$421K ﹤0.01% 5371
2019
Q4 		$475K Sell
91,905
-240
-0.3% -$1.14K ﹤0.01% 4957
2019
Q3 		$558K Sell
92,145
-25
-0% -$217 ﹤0.01% 4633
2019
Q2 		$761K Sell
92,170
-884
-0.9% -$10.5K ﹤0.01% 4381
2019
Q1 		$1.33M Buy
93,054
+47
+0.1% +$646 ﹤0.01% 3911
2018
Q4 		$1.06M Sell
93,007
-163
-0.2% -$2.52K ﹤0.01% 4231
2018
Q3 		$1.86M Sell
93,170
-168
-0.2% -$3.65K ﹤0.01% 4059
2018
Q2 		$2.33M Buy
93,338
+122
+0.1% +$2.94K ﹤0.01% 3925
2018
Q1 		$2.4M Sell
93,216
-103
-0.1% -$2.81K ﹤0.01% 3824
2017
Q4 		$2.38M Buy
93,319
+61,468
+193% +$1.58M ﹤0.01% 3883
2017
Q3 		$894K Buy
31,851
+30,654
+2,561% +$855K ﹤0.01% 4505
2017
Q2 		$35K Sell
1,197
-18
-1% -$510 ﹤0.01% 5951
2017
Q1 		$37K Sell
1,215
-240
-16% -$7.5K ﹤0.01% 5919
2016
Q4 		$50K Sell
1,455
-1,614
-53% -$55.6K ﹤0.01% 5751
2016
Q3 		$202K Buy
3,069
+133
+5% +$8.28K ﹤0.01% 5019
2016
Q2 		$166K Sell
2,936
-2,474
-46% -$139K ﹤0.01% 5023
2016
Q1 		$315K Sell
5,410
-311
-5% -$16.5K ﹤0.01% 4703
2015
Q4 		$337K Sell
5,721
-956
-14% -$56.4K ﹤0.01% 4796
2015
Q3 		$382K Buy
6,677
+291
+5% +$23.4K ﹤0.01% 4758
2015
Q2 		$578K Buy
6,386
+1,355
+27% +$117K ﹤0.01% 4614
2015
Q1 		$485K Sell
5,031
-1,953
-28% -$181K ﹤0.01% 4675
2014
Q4 		$612K Sell
6,984
-2,266
-24% -$195K ﹤0.01% 4524
2014
Q3 		$845K Sell
9,250
-7,444
-45% -$806K ﹤0.01% 4188
2014
Q2 		$1.92M Buy
16,694
+1,792
+12% +$212K ﹤0.01% 3515
2014
Q1 		$1.8M Buy
14,902
+461
+3% +$60.4K ﹤0.01% 3507
2013
Q4 		$1.81M Buy
14,441
+172
+1% +$20.6K ﹤0.01% 3455
2013
Q3 		$1.55M Buy
14,269
+1,526
+12% +$149K ﹤0.01% 3435
2013
Q2 		$1.07M Buy
+12,743
New +$1.06M ﹤0.01% 3676

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley's TRIB Position: Q1 2026 in Review

Morgan Stanley reduced its Trinity Biotech (TRIB) stake by 31% in Q1 2026, selling an estimated $131 and leaving 402 shares worth $218. The position accounts for ﹤0.01% of the portfolio, ranked #7692.

Morgan Stanley first reported a position in TRIB in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.4M in Q1 2018. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Morgan Stanley held 402 shares of Trinity Biotech worth $218 as of Q1 2026.
  • Morgan Stanley sold 178 Trinity Biotech shares in Q1 2026, an estimated $131.
  • Trinity Biotech made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7692 holding.
  • Morgan Stanley first reported a position in Trinity Biotech in Q2 2013 and has held it in 51 quarters since.
  • Morgan Stanley's Trinity Biotech position peaked at $2.4M in Q1 2018.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.